Avloclav 0.6 IV Injection Injection

About Avloclav 0.6 IV Injection 500 mg + 100 mg

Avloclav 0.6 IV Injection is supplied as a 500 mg + 100 mg strength. It is a broad spectrum penicillin injection containing amoxicillin and clavulanic acid, given under medical supervision.

There are 105 brands of Amoxicillin + Clavulanic Acid listed in Bangladesh. The lowest listed price is Moxilin CV 125 mg + 31.25 mg/5 ml Powder For Suspension at ৳ 1 per unit.

What is Avloclav 0.6 IV Injection 500 mg + 100 mg?

Avloclav 0.6 IV Injection contains amoxicillin and clavulanic acid, a combination that belongs to the broad spectrum penicillins. It is an antibacterial injection used for short-term treatment of bacterial infections. The clavulanic acid component helps protect the amoxicillin from being broken down by certain bacterial enzymes, which can extend its activity against some resistant organisms. The doctor decides the dose and course. The injection is given by a healthcare professional, usually in a hospital or clinic setting. Always follow the doctor's advice.

Uses of Avloclav 0.6 IV Injection

Avloclav 0.6 IV Injection is used to treat short-term bacterial infections at several sites. These include upper respiratory tract infections such as tonsillitis, sinusitis and middle ear infection, lower respiratory tract infections such as acute and chronic bronchitis and pneumonia, and genito-urinary tract infections such as cystitis and urethritis. It is a prescription antibiotic and should only be used when a doctor has assessed the infection.

How to use Avloclav 0.6 IV Injection

Avloclav 0.6 IV Injection is administered by a healthcare professional, typically by injection into a vein. The doctor decides the dose and course based on the type and severity of the infection, the patient's age, kidney function and other factors. Do not attempt to give this injection yourself. If you have any questions about how it is given, ask your doctor or pharmacist. Follow all instructions given by the treating team.

Side effects of Avloclav 0.6 IV Injection

Side effects with this antibiotic are usually mild and short-lived. The most common include diarrhoea, indigestion, nausea and vomiting. Yeast infections such as candidiasis may occur, and skin reactions like urticaria and erythematous rash can happen. Rare but serious effects include hepatitis, cholestatic jaundice and severe skin reactions. Allergic reactions such as angioedema and anaphylaxis have been reported with beta-lactam antibiotics. Stop the injection and seek urgent medical help if you notice swelling of the face or throat, difficulty breathing, a severe rash, or persistent diarrhoea. Also contact your doctor if you develop yellowing of the eyes or skin.

Safety and precautions

Avloclav 0.6 IV Injection must not be used in anyone with a history of penicillin allergy or a previous history of jaundice linked to this combination or to penicillin. Cross-reactivity with other beta-lactam antibiotics such as cephalosporins is possible, so tell your doctor about any antibiotic allergy. Use with care if you are on anticoagulation therapy, have severe liver problems or have kidney problems, as dose adjustment may be needed. Pregnancy and breastfeeding: the use of this medicine in pregnancy is not recommended unless the doctor considers it essential. Trace amounts may pass into breast milk. Always tell your doctor if you are pregnant, planning pregnancy or breastfeeding. Ask your doctor or pharmacist before use if any of these apply to you.

Frequently asked questions

What is Avloclav 0.6 IV Injection used for and what kind of medicine is it?

It is a broad spectrum penicillin antibiotic, a combination of amoxicillin and clavulanic acid. It is used for short-term bacterial infections of the upper and lower respiratory tract and the genito-urinary tract. The doctor decides if it is right for the infection.

What side effects should I watch for and when should I call the doctor?

Watch for diarrhoea, nausea, vomiting, indigestion or rash. Call the doctor right away if you have swelling of the face or throat, trouble breathing, a severe skin rash, yellowing of the eyes or skin, or severe or persistent diarrhoea. These may need urgent medical attention.

How should Avloclav 0.6 IV Injection be stored?

Store it below 25°C, protected from light and moisture. It is prepared by a healthcare professional; any unused portion or prepared solution should be handled and discarded as instructed by the hospital or clinic. Ask your pharmacist if you need more storage advice.

Can I use this injection if I am pregnant or breastfeeding?

The use of this medicine in pregnancy is not recommended unless the doctor considers it essential. Trace amounts may pass into breast milk. Tell your doctor if you are pregnant, planning pregnancy or breastfeeding so they can decide what is appropriate for you.

Indications

Co-amoxiclav is indicated for short-term treatment of bacterial infections at the following sites:
  • Upper respiratory tract infections (including ENT) e.g.tonsillitis,sinusitis,otitis media.
  • Lower respiratory tract infections e.g.acute and chronic bronchitis, lobar and bronchopneumonia.
  • ... Read more
Co-amoxiclav is indicated for short-term treatment of bacterial infections at the following sites:
  • Upper respiratory tract infections (including ENT) e.g.tonsillitis,sinusitis,otitis media.
  • Lower respiratory tract infections e.g.acute and chronic bronchitis, lobar and bronchopneumonia.
  • Genito-urinary tract infections e.g.cystitis,urethritis,pyelonephritis.
  • Skin and soft tissue infections.
  • Bone and joint infections e.g.osteomyelitis.
  • Other infections e.g.septic abortion,puerperal sepsis,intra-abdominal sepsis etc.

Pharmacology

Pharmacodynamic properties: Co-amoxiclav is an antibacterial combination consisting of the antibiotic Amoxicillin and the (3-lactamase inhibitor Clavulanic Acid. Amoxicillin has a broad spectrum of bactericidal activity against many Gram-positive & Gram-negative microorganisms but it is susceptible to degradation by (3-lactamases and therefore the spectrum of activity does not include microorganisms, which produce these enzymes. Clavulanic acid possesses the ability to inactivate a wide range of beta-lactamase enzymes commonly found in microorganisms resistant to penicillins and cephalosporins. Thus Clavulanic acid in this preparation protects Amoxicillin from degradation by (3-lactamase enzymes and effectively extends the antibiotic spectrum to embrace a wide range of microorganisms.

Pharmacokinetic properties: The pharmacokinetics of the two components of Co-amoxiclav is closely matched. Peak serum levels of both occur about one hour after oral administration. Absorption of Co-amoxiclav is optimized at the start of a meal. Both clavulanate and Amoxicillin have low levels of serum binding; about 70% remains free in the serum. Doubling the dosage of Co-amoxiclav approximately doubles the serum levels achieved.

Dosage & Administration

Adults and children over 12 years:

Tablet:
  • The usual adult dose is one 625 mg Tablet every 12 hours or one 375 mg Tablet every 8 hours.
  • For more severe infections and infections of the respiratory tract, the dose should be one 1 gm Tablet every 12 hours or one 625 mg Tablet every 8 hours.
Suspension:
  • Children 6-12 years: 2 teaspoonful every 8 hours.
  • Children 1-6years: 1 teaspoonful every 8 hours.
  • Children below 1 year: 25 mg/kg/day in divided doses every 8 hours, for example a 7.5 kg child would require 2 ml suspension t.i.d, Treatment should not be extended beyond 14 days without review.
Forte suspension:
  • The usual recommended daily dosage: 25/3.6 mg/kg/day in mild to moderate infections (upper respiratory tract infections e.g. recurrent tonsilitis, lower respiratory infections, and skin and soft tissue infections)।
  • For serious infections: 45/6.4 mg/kg/day for the treatment of more serious infections (upper respiratory tract infections, e.g. otitis media and sinusitis, lower respiratory infections e.g. bronchopneumonia, and urinary tract infections).
Children of 2 to 12 years:
Mild to moderate infections:
  • 25/3.6 mg/kg/day (Suspension)
  • 2-6 years (13-21 kg) 2.5 ml suspension b.i.d
  • 7-12years (22-40kg) 5 ml suspension b.i.d
Serious infections:
  • 45/6.4 mg/kg/day (Forte Suspension)
  • 2-6 years (13-21 kg) 5 ml suspension b.i.d
  • 7-12 years (22-40 kg) 10 ml suspension b.i.d
IV Injection

Adults-
  • Usually, 1.2 gm every 8 hours
  • Increased in more serious infections to 1.2 gm every 6 hours
  • For surgical prophylaxis: The usual dose is 1.2 gm at induction, for high risk procedures (eg. colorectal surgery) up to 2-3 gm may be given every 8 hours.
Children-
  • 0 to 3 months: 30 mg/kg every 8 hours. (every 12 hours in the perinatal period and in premature infants.
  • 3 months to 12 years: Usually 30 mg/kg every 8 hours increased in more serious infection to 30 mg/kg every 6 hours.

Interaction

Prolongation of bleeding time and prothrombin time have been reported in some patients receiving Co-amoxiclav. In common with other broad-spectrum antibiotics, Co-amoxiclav may reduce the efficacy of oral contraceptives and patients should be warned accordingly. Concomitant use of allopurinol during treatment with amoxicillin can increase the likelihood of allergic skin reactions. There are no data on the concomitant use of Co-amoxiclav and allopurinol.

Contraindications

History of Penicillin hypersensitivity. Attention should be paid to possible cross-sensitivity with other beta-lactam antibiotics e.g. cephalosporins. Also contraindicated for patients with a previous history of Co-amoxiclav or Penicillin-associated cholestatic jaundice.

Side Effects

Side effects, as with Amoxicillin, are uncommon and mainly of a mild and transitory nature. Diarrhoea, pseudomembranous colitis, indigestion, nausea, vomiting and candidiasis have been reported, if gastrointestinal side effects occur with oral therapy, that may be reduced by taking Co-amoxiclav at the start of meals. Hepatitis and cholestatic jaundice have been reported rarely but are usually reversible. Urticarial and erythematous rashes sometimes occur. Rarely erythema multiforme, Stevens-Johnson Syndrome and exfoliative dermatitis have been reported. In common with other beta-lactam antibiotics, angioedema and anaphylaxis have been reported.

Pregnancy & Lactation

Animal studies with orally and parenterally administered Co-amoxiclav have shown no teratogenic effect. The drug has been used orally in human pregnancy in a limited number of cases with no untoward effect; however, the use of Co-amoxiclav in pregnancy is not recommended unless considered essential by the physician. During lactation, trace quantities of Amoxicillin can be detected in breast milk.

Precautions & Warnings

Co-amoxiclav should be used with care in patients on anticoagulation therapy or with severe hepatic dysfunction. In patients with moderate or severe renal impairment, dosage should be adjusted. During the administration of a high dose of Co-amoxiclav adequate fluid intake and urinary output should be maintained to minimize the possibility of crystalluria.

Overdose Effects

Problems of overdose with Co-amoxiclav are unlikely to occur, if encountered gastrointestinal symptoms and disturbance of the fluid and electrolyte balances may be evident. Co-amoxiclav may be removed from the circulation by haemodialysis.

Storage Conditions

This should be stored below 25°C, protected from light and moisture. Once reconstituted suspension should be kept in the refrigerator (but not frozen) and should be usedby 7 days. Once reconstituted vial must be used within 20 minutes.

Alternative brands of Amoxicillin + Clavulanic Acid

Other brands with the same generic name, cheapest first.

See all 105 brands

Medicine information is for reference only and is not medical advice. Always follow your doctor's prescription and check with a pharmacist.